Order results by:
| Issue | Title | |
| Vol 8, No 2 (2016) | Ultrasound-guided botulinum toxin injections | Abstract similar documents |
| S. E. Khatkova, A. A. Balbert | ||
| "... in the pathological process. The exact entry of botulinum toxin into the target muscles is essential for successful ..." | ||
| Vol 14, No 3 (2022) | Hemimasticatory spasm: possibilities of treatment with injections of botulinum neuroprotein type A (case report) | Abstract similar documents |
| L. U. Valieva, A. S. Pankratov, O. R. Orlova | ||
| "... with hemimasticatory spasm (HMS) with injections of botulinum neuroprotein type A (BNPA). The authors present ..." | ||
| Vol 16, No 6 (2024) | Updated and revised Russian consensus on the use of multilevel injections of abobotulinumtoxin A in children | Abstract similar documents |
| A. L. Kurenkov, O. A. Klochkova, V. A. Zmanovskaya, I. V. Falkovskiy, V. M. Kenis, L. N. Vladykina, D. A. Krasavina, A. S. Nosko, L. V. Rychkova, Kh. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, A. M. Mamedyarov, L. M. Kuzenkova, O. G. Dontzov, M. A. Ryzhenkov, M. N. Butorina, D. M. Dankov, E. V. Levitina, D. A. Popkov, S. O. Ryabykh, O. V. Agranovich, T. I. Kiseleva, O. N. Vasileva, V. P. Zykov, V. I. Mihnovich, T. A. Belogorova | ||
| "... injections, ethical and legal aspects of botulinum therapy in children, the combination of botulinum therapy ..." | ||
| Vol 13, No 6 (2021) | Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, Z. A. Zalyalova, A. F. Ivolgin | ||
| "... ). Botulinum neurotoxin (BoNT) injections is the treatment choice for CD. However, the effectiveness ..." | ||
| Vol 8, No 2 (2016) | Possibilities of using computed tomography to treat mixed cervical dystonia with botulinum toxin type A | Abstract similar documents |
| T. V. Mokina, Yu. I. Pavlov, Z. A. Zalyalova | ||
| "... muscles of the neck were beyond the reach of injection. Routine clinical examination cannot identify ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... Objective: to evaluate the efficacy and safety of botulinum toxin type A (BTA) injections ..." | ||
| Vol 9, No 3 (2017) | Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke | Abstract similar documents |
| V. V. Gusev, O. A. Lvova, T. V. Balueva | ||
| "... manufacturers. Results. The clinical efficiency of local intramuscular injection of the botulinum toxin type ..." | ||
| Vol 12, No 6 (2020) | Mapping the limb muscle motor points for targeted administration of botulinum toxin in the treatment of focal and segmental spasticity | Abstract similar documents |
| A. P. Kovalenko, K. A. Sinelnikov, V. D. Shamigulov, N. N. Akhmedov, E. M. Shamina | ||
| "... injection of botulinum neurotoxin (BoNT) into the muscle motor points (MPs) is gaining more and more ..." | ||
| Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
| S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
| "... to that at the baseline visit. The greatest muscle tone reduction was observed at 1 and 2 months after injection ..." | ||
| Vol 12, No 5 (2020) | Cervical dystonia: current rehabilitation strategies and methods | Abstract similar documents |
| A. S. Istomina, I. V. Miliukhina, M. D. Didur | ||
| "... , and increasing the intervals between botulinum toxin injections and lowering the dose of the drug administered. ..." | ||
| Vol 16, No 2 (2024) | Modelling long-term outcomes and mortality risk in patients with post-stroke spasticity during abobotulinum toxin injections as part of rehabilitation | Abstract similar documents |
| S. E. Khatkova, A. S. Gilweg | ||
| "... of botulinum therapy (abobotulinum toxin injections – AboBTX) during rehabilitation in patients with post ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... disabling neurological diseases. Objective: to investigate the structure of spastic muscles in patients ..." | ||
| Vol 9, No 2 (2017) | A multidisciplinary approach to treating musculoarticular dysfunction of the temporomandibular joint with obvious pain syndrome | Abstract similar documents |
| O. A. Shakhmetova, T. M. Sinitsina | ||
| "... type A injection into the masticatory muscles. Patients and methods. The investigation enrolled 20 ..." | ||
| Vol 17, No 2 (2025) | 12-year experience of incobotulinumtoxinA use in neurological practice | Abstract similar documents |
| N. V. Kireeva, E. G. Bukreeva, D. S. Kireev | ||
| "... of patients and injection cycles, average dosage, number, and types of adverse events (AEs) and reported cases ..." | ||
| Vol 13, No 5 (2021) | Effectiveness of early abobotulinum toxin (Dysport®) injections in patients with upper limb spastic paresis after traumatic brain injury in real clinical practice: results of a multicenter observational non-interventional prospective study (Adults with post Traumatic Brain Injury (TBI) upper limb (UL) spasticity – APTULS) | Abstract similar documents |
| S. E. Khatkova, V. P. Diagileva, L. V. Krylova, D. V. Pokhabov, A. G. Arutiunian | ||
| "... at evaluating of the clinical results early using injections of abobotulinumtoxinA (Abo-BTA, Dysport ..." | ||
| Vol 14, No 1 (2022) | Treatment of spasticity in patients with the consequences of traumatic brain injury | Abstract similar documents |
| A. P. Kovalenko, I. A. Vozniuk, K. M. Naumov, V. Yu. Lobzin, S. Yu. Kirtaev | ||
| "... , data on the effectiveness of botulinum neurotoxin (BoNT) in the treatment of post-traumatic spasticity ..." | ||
| Vol 13, No 2 (2021) | Gait rehabilitation in patients with spastic hemiparesis: new opportunities | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, A. S. Rodionov, D. I. Kremlyov, D. V. Averkiev, V. Yu. Lobzin, A. V. Guseva | ||
| "... of botulinum neurotoxin (BNT) under ultrasound control into the spastic muscles of the lower limb ..." | ||
| Vol 14, No 2 (2022) | Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea | Abstract PDF (Eng) similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, B. I. Bursagova, V. V. Chernikov, O. V. Agranovich, L. G. Khachatryan, V. M. Kenis, V. A. Zherebtsova, M. N. Sarzhina, N. D. Odinaeva, A. R. Artemenko, G. A. Popova, E. A. Moroshek, E. E. Tabe, A. A. Nezhelskaya, A. A. Maksimenko, L. Ya. Akhadova, M. V. Indereikin, N. V. Duibanova, L. V. Tikhonova, A. V. Sapogovskiy, Z. M. Gadzhialieva, A. V. Grigorieva, V. S. Perminov, I. D. Fedonyuk, L. M. Kolpakchi, A. Yu. Kursakova, N. A. Tsurina | ||
| "... Botulinum therapy for cerebral palsy (CP) is considered not only as one of the effective ..." | ||
| Vol 17, No 2 (2025) | Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke | Abstract similar documents |
| V. V. Gusev, T. V. Balueva, O. V. Zayceva, D. A. Smirnov | ||
| "... and increase the risk of aspiration pneumonia. Botulinum toxin type A (BoNT-A) injections are effective ..." | ||
| Vol 14, No 6 (2022) | Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice | Abstract similar documents |
| R. K. Shikhkerimov, E. V. Istomina | ||
| "... Currently, eight natural serotypes of botulinum neurotoxin (BNT-A-G, -X) are known. The mechanism ..." | ||
| Vol 13, No 1 (2021) | Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy | Abstract similar documents |
| Z. A. Zalyalova | ||
| "... production, is the ability to vary between-injection intervals. Probably, botulinum toxin therapy has ..." | ||
| Vol 16, No 1 (2024) | Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) | Abstract similar documents |
| A. L. Kurenkov, B. I. Bursagova, A. R. Artemenko | ||
| "... with impairment of the child’s daily life. Recently, more studies have been published on the use of botulinum ..." | ||
| Vol 13, No 5 (2021) | Spasticity syndrome in cerebral pathology: evaluation and clinical models | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, I. A. Voznyuk, V. K. Misikov | ||
| "... Knowing the frequency of spasticity patterns in different muscles allows correcting the botulinum ..." | ||
| Vol 2, No 4 (2010) | Pericranial muscle dysfunction in primary headache and its correction | Abstract similar documents |
| V. V. Osipova | ||
| "... The paper deals with a role of muscle dysfunction in primary headache disorders, such as migraine ..." | ||
| Vol 11, No 3 (2019) | A case of segmental dystonia with mental/psychic nonmotor disorders | Abstract similar documents |
| V. A. Tolmacheva, D. V. Romanov, D. A. Grishina | ||
| "... The paper discusses the specific features of clinical presentations in patients with muscle ..." | ||
| Vol 13, No 4 (2021) | Rehabilitation approaches in cervical dystonia | Abstract similar documents |
| Z. A. Zalyalova, E. R. Iusupova | ||
| "... disturbances, and pain. Current CD treatment guidelines include botulinum toxin (BT) injections as first-line ..." | ||
| Vol 5, No 1 (2013) | Skeletal muscle involvement in patients with chronic alcoholic intoxication | Abstract similar documents |
| Olga Evgenyevna Zinovyeva, N S Shcheglova, Y V Kazantseva, B S Shenkman, E G Altayeva | ||
| "... is postulated to be impaired protein synthesis in the muscle fibers. A comprehensive clinical, biochemical ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... , botulinum therapy can be an effective tool that significantly reduces sialorrhea manifestation. Oblective ..." | ||
| Vol 3, No 4 (2011) | Mechanisms in the pathogenesis of poststroke spasticity | Abstract similar documents |
| E. A. Katushkina, O. E. Zinovyeva, B. S. Shenkman, N. N. Yakhno | ||
| "... and functional impairments of skeletal muscles in its pathogenesis. Patients and methods. Thirty-two patients ..." | ||
| Vol 12, No 2 (2020) | Myofascial pain syndrome in female patients with chronic nonspecific back pain: diagnosis and treatment | Abstract similar documents |
| D. O. Rozhkov, O. E. Zinovyeva, A. N. Barinov, I. M. Vikhlyantsev, G. Z. Mikhailova, N. V. Penkov, A. M. Nosovsky | ||
| "... facet joints (FJs); sacroiliac joints (SIJs); skeletal muscles with the development of MFPS; MFPS ..." | ||
| Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
| V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
| "... stages. The efficacy of long-term botulinum therapy (BT) in CD has been poorly studied. Objective ..." | ||
| Vol 10, No 3 (2018) | Non-motor disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, M. R. Nodel, N. I. Saloukhna | ||
| "... Botulinum toxin injection therapy is the mainstay for managing patients with motor manifestations ..." | ||
| Vol 11, No 1 (2019) | Change in the content of titin and nebulin and their phosphorylation level in the quadriceps femoris muscle in chronic alcoholic myopathy | Abstract PDF (Eng) similar documents |
| O. E. Zinovyeva, N. D. Samkhaeva, I. M. Vikhlyantsev, A. D. Ulanova, G. Z. Mikhailova, N. S. Shcheglova, D. O. Kazakov, A. Yu. Emelyanova, A. M. Nosovsky | ||
| "... Objective: to assess the structural and functional state of skeletal muscles in the hip, as well ..." | ||
| Vol 12, No 3 (2020) | Arm spasticity after stroke: botulinum toxin therapy in combination with multimodal stimulation | Abstract similar documents |
| V. N. Lutsik, E. V. Slyunkova, S. V. Kotov, V. K. Misikov, E. V. Biryukova | ||
| "... of botulinum toxin A (BTA) and multimodal stimulation in patients with arm PS. Patients and methods ..." | ||
| Vol 12, No 6 (2020) | Nonsteroidal anti-inflammatory drugs, muscle relaxants, and B-group vitamins in the treatment of lumbar ischialgia | Abstract similar documents |
| V. A. Shirokov, A. V. Potaturko, N. L. Terekhov | ||
| "... Nonsteroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants are used orally ..." | ||
| Vol 7, No 2 (2015) | Neuromuscular disorders in chronic alcohol intoxication | Abstract similar documents |
| A. Yu. Emelyanova, O. E. Zinovyeva, N. D. Samkhaeva, N. S. Shcheglova | ||
| "... polyneuropathy (PNP) and alcohol-induced skeletal muscle injury. The clinical polymorphism of alcoholic PNP ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... and tolerability. In the group of patients with MOH, the best results were obtained when using injection methods ..." | ||
| Vol 9, No 2 (2017) | Role of a muscle factor in the development of low back pain | Abstract similar documents |
| A. I. Isaikin, G. E. Shevtsova, D. O. Rozhkov, A. V. Kavelina, M. A. Ivanova | ||
| "... for a link between the status of spinal muscles (according to magnetic resonance imaging and computed ..." | ||
| Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova | ||
| "... . The hypothesis of the leading role of myofascial trigger points (MTPs) in muscle pain remains debatable. Probably ..." | ||
| Vol 10, No 4 (2018) | Chemoreactome analysis of tolperisone, tizanidine, and baclofen molecules: anticholinergic, antispasmodic, and analgesic mechanisms of action | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov | ||
| "... Muscle relaxants are used in the treatment of musculoskeletal pain. The exact molecular mechanisms ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... the frequency of injections, which contributes to higher adherence to the treatment. ..." | ||
| Vol 9, No 1 (2017) | Scapulohumeral periarthritis | Abstract similar documents |
| A. I. Isaikin, M. A. Ivanova | ||
| "... “scapulohumeral periarthritis” encompasses injuries of both the muscles and the joint capsule proper. It is more ..." | ||
| Vol 8, No 4 (2016) | POSTSTROKE SPASTICITY: AN INDIVIDUALIZED APPROACH TO TREATMENT | Abstract similar documents |
| V. A. Tolmacheva | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... a leading role in the treatment of poststroke spasticity. The local administration of botulinum toxin ..." | ||
| Vol 2, No 3 (2010) | Treatment for spasticity after stroke | Abstract similar documents |
| S. E. Khatkova | ||
| "... for post-stroke spasticity therapy with botulinum, in particular botulinum toxin type A (Xeomin) used ..." | ||
| Vol 12, No 4 (2020) | Discogenic lumbosacral radiculopathy. Recommendations of the Russian Association for the Study of Pain (RSSP) | Abstract similar documents |
| V. A. Parfenov, N. N. Yakhno, O. S. Davydov, M. L. Kukushkin, M. V. Churyukanov, V. A. Golovacheva, G. Yu. Evzikov, A. I. Isaikin, M. A. Ivanova, A. E. Karateev, A. V. Amelin, E. E. Achkasov, L. R. Akhmadeeva, M. A. Bakhtadze, E. R. Barantsevich, A. E. Barulin, A. N. Belova, G. N. Belskaya, V. G. Bychenko, O. B. Doronina, O. N. Dreval, O. I. Zagorulko, E. D. Isagulyan, D. A. Iskra, P. P. Kalinsky, Yu. V. Karakulova, O. V. Kurushina, L. A. Medvedeva, D. M. Merkulova, A. P. Rachin, D. A. Sergienko, I. A. Strokov, F. A. Khabirov, V. A. Shirokov, E. Z. Yakupov | ||
| "... , and no epidural glucocorticoid injection or urgent surgical treatment is scheduled, there is no reason for early ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Surgical and medical treatments for discogenic low back radiculopathy | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. O. Isaikin | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| "... ) poor tolerability due to frequent injections (every other day), 3) severe local reactions and flu-like ..." | ||
| Vol 16, No 5 (2024) | Muscle relaxers in acute musculoskeletal back pain | Abstract similar documents |
| A. Kh. Mukhametzyanova, A. I. Isaikin | ||
| "... ) and muscle relaxers (MR). Most modern clinical guidelines recommend non-benzodiazepine MR as the treatment ..." | ||
| Online-first | Ведение пациентов с болевыми синдромами на фоне COVID-19 | Abstract similar documents |
| L. Т. Аkhmedzhanova, T. M. Ostroumova, O. A. Solokha | ||
| "... and in the postcoid period. The cause of muscle and joint damage is both systemic inflammation and direct damage ..." | ||
| Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
| D. V. Zakharov, D. D. Kokareva | ||
| "... to correct their combination in Parkinson's disease with the possibility of reducing polypharmacy. Botulinum ..." | ||
| Vol 13, No 5 (2021) | Management of patients with pain syndromes associated with COVID-19 | Abstract similar documents |
| L. T. Akhmedzhanova, T. M. Ostroumova, O. A. Solokha | ||
| "... be observed both at the onset of the disease and in the postcovid period. The causes of muscle and joint ..." | ||
| Vol 9, No 2 (2017) | Muscle relaxants as alternative analgesics in the treatment of nonspecific back pain | Abstract similar documents |
| G. R. Tabeeva | ||
| "... . The widespread administration of muscle relaxants is traditional in clinical practice because of their high ..." | ||
| Vol 4, No 2 (2012) | Influence of a complex of muscle-strengthening exercises on quality of life in lumbosacral pain | Abstract similar documents |
| I A Zaitseva | ||
| "... Objective: to elaborate and substantiate an algorithm of a complex of muscle-strengthening ..." | ||
| Vol 6, No 2 (2014) | Epidural glucocorticoid use for vertebrogenic pain | Abstract similar documents |
| M.V. Churyukanov, O.A. Chernenko | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... and radiological activity of the disease during dimethyl fumarate therapy. After the first injection, hyperthermia ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... and radiological activity of the disease during dimethyl fumarate therapy. After the first injection, hyperthermia ..." | ||
| Vol 15, No 6 (2023) | Admitting a patient with musculoskeletal pain following COVID-19 disease | Abstract similar documents |
| I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova | ||
| "... : the first three injections (day 1, 3, and 5) 1 ml (100 mg), then, from the fourth injection (day 7) – 2 ml ..." | ||
| Vol 11, No 2 (2019) | Differential chemoreactome analysis of synergistic combinations of tolperisone and nonsteroidal anti-inflammatory drugs | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, A. N. Gromov | ||
| "... The concurrent use of muscle relaxants and nonsteroidal anti-inflammatory drugs (NSAIDs ..." | ||
| Vol 6, No 3 (2014) | Myofascial pain: from Virchow's to our days | Abstract similar documents |
| I. V. Egorov | ||
| "... as impaired function of one or other muscle, which occurs with its overload and manifests itself as muscle ..." | ||
| Vol 12, No 6 (2020) | Contemporary views of the mechanisms for development of myofascial pain syndrome and its treatment strategies | Abstract similar documents |
| G. R. Tabeeva, E. A. Kiryanova | ||
| "... and is characterized by the presence of a trigger point in the muscle involved in the pathological process. Clarifying ..." | ||
| Vol 12, No 3 (2020) | Experience with chondroitin sulfate in the combination therapy of lower back pain | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, Yu. S. Prokofyeva | ||
| "... injections at a dose of 1 ml (100 mg) on days 1, 3, and 5; if this was well tolerable, a dose of 2 ml (200 mg ..." | ||
| Vol 16, No 3 (2024) | Fremanezumab in real-life clinical practice: specialized headache center experience | Abstract similar documents |
| Yu. E. Azimova, K. V. Skorobogatikh, V. V. Osipova, D. Z. Korobkova, N. V. Vashchenko, E. Z. Mamkhegov, A. S. Galanina, E. A. Guziy | ||
| "... at least three injections of FRE 225 mg or three injections with a total dose of 675 mg and regularly ..." | ||
| Vol 12, No 4 (2020) | Tolperisone in the treatment of acute and chronic nonspecific back pain | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, O. E. Zinovyeva, V. L. Golubev | ||
| "... , and vertebral canal stenosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants are used ..." | ||
| Vol 11, No 1 (2019) | Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov | ||
| "... The pathogenesis of sarcopenia is complex and associated with impaired muscle protein synthesis ..." | ||
| Vol 8, No 1 (2016) | Migraine and neck pain: Mechanisms of comorbidity | Abstract similar documents |
| A. S. Zenkevich, E. G. Filatova, N. V. Latysheva | ||
| "... of neck muscles were more marked. There was also a significant reduction in WR and NFR thresholds. Neck ..." | ||
| Vol 9, No 3 (2017) | Molecular effects of chondroguard in osteoarthritis and herniated discs | Abstract similar documents |
| A. M. Lila, O. A. Gromova, I. Yu. Torshin, A. G. Nazarenko, A. Yu. Gogolev | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
| A. A. Kholin | ||
| "... . At the same time, only the injection form of valproate (convulex) could stabilize progressive worsening ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Cubital tunnel syndrome: current principles of diagnosis and treatment | Abstract similar documents |
| V. A. Golovacheva, V. A. Parfenov, A. A. Golovacheva, G. Yu. Evzikov, R. M. Yusupova, N. S. Shcheglova, M. G. Zonov, M. G. Bashlachev | ||
| "... hand muscle weakness and atrophy. The paper considers the etiology, pathogenesis, and risk factors ..." | ||
| Vol 12, No 1 (2020) | Comparative efficacy and tolerance of centrally acting muscle relaxants in elderly patients with nonspecific musculoskeletal pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, I. A. Zolotovskaya, V. A. Kruglov | ||
| "... took a muscle relaxant as tablets for 15 days: Group 1 received the Russian drug tolperisone (calmyrex ..." | ||
| 1 - 70 of 161 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
